Hybio Pharmaceutical Co., Ltd. (SHE:300199)
China · Delayed Price · Currency is CNY 22.10
+2.33 (11.79%)
Jun 29, 2026, 3:04 PM CST
Hybio Pharmaceutical Market Cap
Hybio Pharmaceutical has a market cap or net worth of 19.52 billion as of June 29, 2026. Its market cap has increased by 54.65% in one year.
Market Cap
19.52B
Enterprise Value
21.39B
Revenue
955.53M
Ranking
n/a
PE Ratio
216.09
Stock Price
22.10
Market Cap Chart
Since April 7, 2011, Hybio Pharmaceutical's market cap has increased from 2.93B to 19.52B, an increase of 566.20%. That is a compound annual growth rate of 13.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 29, 2026 | 19.52B | 23.46% |
| Dec 31, 2025 | 15.81B | 38.87% |
| Dec 31, 2024 | 11.38B | -5.08% |
| Dec 29, 2023 | 11.99B | -22.75% |
| Dec 30, 2022 | 15.53B | 39.41% |
| Dec 31, 2021 | 11.14B | 88.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tasly Pharmaceutical Group | 19.78B |
| Guangdong Zhongsheng Pharmaceutical | 19.20B |
| Shanghai Haoyuan Chemexpress | 19.12B |
| Walvax Biotechnology | 18.66B |
| Jiangsu Nhwa Pharmaceutical Co., LTD | 18.52B |
| Chengdu Kanghong Pharmaceutical Group | 17.98B |
| Apeloa Pharmaceutical Co.,Ltd | 17.97B |
| Dizal (Jiangsu) Pharmaceutical | 16.97B |